Li et al. investigated transferrin conjugated CDs (9–12 nm) for the selective delivery of DOX to pediatric brain cancer cells because the transferrin receptor (TfR) can be overexpressed on the BBB as well as in cancer cells [117]. The gene discussed is TFRC; the disease is cancer.